Clinical trial
Spectral Diagnosis of Cutaneous Malignancy
NCT00476905 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00476905 |
|---|---|
| Title | Spectral Diagnosis of Cutaneous Malignancy |
| Official title | Spectral Diagnosis of Cutaneous Malignancy |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | University of Texas at Austin |
| Status | Completed |
| Study type | Observational |
| Conditions | Skin Cancer |
| Intervention type | Device |
| Interventions | Spectral Diagnosis Probe |
| Enrollment | 350 |
| Start date | Apr 1, 2007 |
| Primary completion | Nov 20, 2018 |
| Completion | Nov 20, 2018 |
| First posted | May 22, 2007 |
| Last update posted | May 20, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: